T1-2N1M0 nasopharyngeal carcinoma chemotherapy or not: A retrospective study.

T1-2N1M0 nasopharyngeal carcinoma chemotherapy or not: A retrospective study.

Show other versions (1)

<h4>Background</h4>Radiotherapy (RT) combined with chemotherapy is the standard treatment for T1-2N1M0 nasopharyngeal carcinoma (NPC) based on conventional radiotherapy. However, intensity-modulated radiotherapy (IMRT) has narrowed the treatment gap between RT and chemoradiotherapy. Thus...

Full description

Bibliographic Details
Main Authors:	Pei-Jing Li, Ming Chen, Ye Tian
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0279252

Similar Items

T1-2N1M0 nasopharyngeal carcinoma chemotherapy or not: A retrospective study
by: Pei-Jing Li, et al.
Published: (2023-01-01)

Explore the Value of Adding Induction Chemotherapy to Concurrent Chemoradiotherapy in T3-4N0M0 Nasopharyngeal Carcinoma Patients: A Retrospective Study [Corrigendum]
by: Li P, et al.
Published: (2022-05-01)

Explore the Usefulness of Concurrent Chemotherapy in Stage II Nasopharyngeal Carcinoma: A Retrospective Study
by: Pei-Jing Li, et al.
Published: (2021-09-01)

Maintenance chemotherapy using S-1 following definitive chemoradiotherapy in patients with N3 nasopharyngeal carcinoma
by: Jingfeng Zong, et al.
Published: (2019-10-01)

Neoadjuvant Chemotherapy in Nasopharyngeal Carcinoma
by: Khudair J. Sabeeh Al-Rawaq
Published: (2012-04-01)

Role of chemotherapy in nasopharyngeal carcinoma
by: Fabiola Paiar, et al.
Published: (2012-06-01)

Adjuvant Chemotherapy in pT2N0M0 Gastric Cancer: Findings From a Retrospective Study
by: Yu Mei, et al.
Published: (2022-02-01)

Safety and efficacy of S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy: multi-institutional retrospective analysis
by: Peng PJ, et al.
Published: (2014-08-01)

A retrospective study of concurrent chemoradiotherapy plus S-1 adjuvant chemotherapy on curative effect for treatment of patients with N3 stage nasopharyngeal carcinoma
by: Zhang S, et al.
Published: (2018-06-01)

Prognostic factors in surgically treated tongue squamous cell carcinoma in stage T1‐2N0‐1M0: A retrospective analysis
by: Wenxi Wang, et al.
Published: (2024-02-01)

Induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma
by: Wen-Fei Li, et al.
Published: (2016-11-01)

Efficacy of Chemotherapy in Survival of Stage I Nasopharyngeal Carcinoma
by: Jia-Lin Ma, et al.
Published: (2021-10-01)

The short-term efficacy and safety of induction chemotherapy combined with PD-1 inhibitor or anti-EGFR in locoregionally advanced nasopharyngeal carcinoma
by: Xiaoyong Xiang, et al.
Published: (2023-04-01)

The pattern of relapse and survival of elective irradiation of the upper neck for stage N0 nasopharyngeal carcinoma
by: He Xiayun, et al.
Published: (2012-03-01)

PD-1 high expression predicts lower local disease control in stage IV M0 nasopharyngeal carcinoma
by: Feng Jiang, et al.
Published: (2019-05-01)

Indications for adjuvant chemotherapy in patients with AJCC stage IIa T3N0M0 and T1N2M0 gastric cancer—an east and west multicenter study
by: Ze-Ning Huang, et al.
Published: (2019-12-01)

Retrospective Analysis of the Survival Benefit of Induction Chemotherapy in Stage IVa-b Nasopharyngeal Carcinoma.
by: Xiao-Wen Lan, et al.
Published: (2016-01-01)

Necessity of concurrent chemotherapy in N2‐3 nasopharyngeal carcinoma treated with neoadjuvant chemotherapy of ≥3 cycles followed by intensity‐modulated radiotherapy
by: Hui Chang, et al.
Published: (2019-06-01)

Durable control of metastatic nasopharyngeal carcinoma with metronomic chemotherapy
by: Po-Hsiang Huang, et al.
Published: (2017-03-01)

Anti-PD1 checkpoint inhibitor with or without chemotherapy for patients with recurrent and metastatic nasopharyngeal carcinoma
by: Ting Jin, et al.
Published: (2021-02-01)

Phase II study of gemcitabine plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy
by: PeiJian Peng, et al.
Published: (2016-05-01)

Low‐dose metronomic chemotherapy improves tumor control in nasopharyngeal carcinoma
by: Yu‐Pei Chen, et al.
Published: (2022-10-01)

The Survival Outcomes of T1aN0M0 Triple-Negative Breast Cancer With Adjuvant Chemotherapy
by: Wen-Fen Fu, et al.
Published: (2020-09-01)

The role of chemotherapy in the treatment of stage II nasopharyngeal carcinoma: Retrospective analysis of the national cancer database
by: Zaheer Ahmed, et al.
Published: (2019-04-01)

Can neoadjuvant chemotherapy improve survival in stage T3-4N1 nasopharyngeal carcinoma? A propensity matched analysis
by: Lei Wang, et al.
Published: (2020-07-01)

A Nomogram to Identify the Optimal Candidates for Induction Chemotherapy in Advanced N-Stage Nasopharyngeal Carcinoma
by: Jiang YT, et al.
Published: (2022-08-01)

Selection and Validation of Induction Chemotherapy Beneficiaries Among Patients With T3N0, T3N1, T4N0 Nasopharyngeal Carcinoma Using Epstein-Barr Virus DNA: A Joint Analysis of Real-World and Clinical Trial Data
by: Cheng Xu, et al.
Published: (2019-11-01)

SOX1 acts as a tumor hypnotist rendering nasopharyngeal carcinoma cells refractory to chemotherapy
by: Xin-Xing Lei, et al.
Published: (2023-06-01)

Clinical efficacy of adjuvant chemotherapy for locally advanced nasopharyngeal carcinoma
by: YANG Xiu, et al.
Published: (2022-11-01)

Effect of Induction Chemotherapy in Nasopharyngeal Carcinoma: An Updated Meta-Analysis
by: Shan-Shan Yang, et al.
Published: (2021-01-01)

Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection
by: Xiao-hui Li, et al.
Published: (2022-11-01)

Prognostic Effects of Different Courses of Neoadjuvant Chemotherapy on Stage N2-3 Locally Advanced Nasopharyngeal Carcinoma
by: PENG Haihua, et al.
Published: (2019-05-01)

Interaction of chemotherapy and radiotherapy in altering the shape of subcortical structures in patients with nasopharyngeal carcinoma
by: Feibiao Nan, et al.
Published: (2022-09-01)

LMP-1 and Nasopharyngeal Carcinoma (NPC)
by: Anggun Indah Budiningrum, et al.
Published: (2014-06-01)

Oral Maintenance Chemotherapy Using S-1/Capecitabine in Metastatic Nasopharyngeal Carcinoma Patients After Systemic Chemotherapy: A Single-Institution Experience [Corrigendum]
by: Guo Q, et al.
Published: (2020-03-01)

Nutritional and clinical outcomes of chemoradiotherapy for clinical T1N0M0 esophageal carcinoma
by: Sakanaka K, et al.
Published: (2019-04-01)

Adjuvant chemotherapy could not bring survival benefit to HR-positive, HER2-negative, pT1b-c/N0–1/M0 invasive lobular carcinoma of the breast: a propensity score matching study based on SEER database
by: Guangfu Hu, et al.
Published: (2020-02-01)

The efficacy and toxicities of intensive induction chemotherapy followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma patients with N3 disease
by: Yingying Zhang, et al.
Published: (2017-06-01)

Chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Who really needs it
by: Weiling Qu, et al.
Published: (2023-03-01)

The Current Role of Adjuvant Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma
by: Lin Su, et al.
Published: (2021-02-01)